Colombian patients with rare disease are advocating for quicker diagnosis and improved access to care, highlighting systemic issues at Raremed 2025 that demand urgent public policy reform.
- During the Raremed 2025 congress in Colombia, patients highlighted that diagnosis of rare disease can take between five to 30 years, severely impacting lives.
- Experts, including the chief executive officer of a leading health organization, emphasized the need for innovation in treatments for rare disease to ensure timely access to care.
- The event addressed how the lengthy diagnosis process for rare disease patients in Colombia mirrors challenges faced in the United States Congress, stressing the need for collaborative solutions.
Por Qué Es Relevante
The call for faster diagnosis and better care access in Colombia reflects a global urgency for advancements in public policy regarding rare disease, potentially influencing international health strategies and funding.